Research Site 7812 - Joliet Oncology-Hematology Associates, Ltd. — Joliet, Illinois

Research Site 7812 - Joliet Oncology-Hematology Associates, Ltd. is a clinical research site located in Joliet, Illinois, United States 60435.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Research Site 7812 - Joliet Oncology-Hematology Associates, Ltd. has participated in 1 clinical trials.

Therapeutic areas: Carcinoma, Non-Small-Cell Lung.

Sponsors: Centus Biotherapeutics Limited.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Joliet

Browse all research sites in Illinois · View every site in Joliet

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site 7812 - Joliet Oncology-Hematology Associates, Ltd.?

Research Site 7812 - Joliet Oncology-Hematology Associates, Ltd. has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site 7812 - Joliet Oncology-Hematology Associates, Ltd. conducted?

Research Site 7812 - Joliet Oncology-Hematology Associates, Ltd. has 1 clinical trials on record. Their work covers Carcinoma, Non-Small-Cell Lung.

Is Research Site 7812 - Joliet Oncology-Hematology Associates, Ltd. accredited by Crixeo Clinical Trials?

Research Site 7812 - Joliet Oncology-Hematology Associates, Ltd. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site 7812 - Joliet Oncology-Hematology Associates, Ltd.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.